SkyePharma, an oral and inhalation drug development company, has hired David Lescuyer as Executive Vice President, Oral Business, reporting to Peter Grant, CEO.
Lescuyer will be responsible for SkyePharma’s Oral Business including, once the lease with Aenova, has expired on 30 June, the manufacturing operations in Saint-Quentin Fallavier, near Lyon, France.
With immediate effect, Guy Vergnault, Vice President, Oral Drug Delivery Solutions, will report to Lescuyer.
Lescuyer joins from Patheon Pharmaceuticals where he was Executive Director and General Manager, Patheon France and more recently Global VP, Operational Excellence.
Prior to Patheon, Lescuyer worked at Fareva, Cenexi and Catalent in senior operational and general management roles.
